Cas:344782-49-6 2-[7-(1,3,2-dioxaborinan-2-yl)-9,9-bis(2-ethylhexyl)fluoren-2-yl]-1,3,2-dioxaborinane manufacturer & supplier

Chemical Name:2-[7-(1,3,2-dioxaborinan-2-yl)-9,9-bis(2-ethylhexyl)fluoren-2-yl]-1,3,2-dioxaborinane

CAS.NO:344782-49-6

Synonyms:MFCD03701633;9,9-Di(2-ethylhexyl)fluorene-2,7-bis(trimethylene borate) solution;9,9-Di(2 inverted exclamation marka-ethylhexyl)fluorene-2,7-bis(trimethylene borate) solution;2,2′-((9,9-Bis(2-ethylhexyl)-9H-fluorene-2,7-diyl)bis(oxy))bis(1,3,2-dioxaborinane);9,9-Di(2-ethylhexyl)fluorene-2,7-diboronic acid bis(1,3-propanediol) ester solution

Molecular Formula:C₃₅H₅₂B₂O₄

Molecular Weight:558.40700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:117-118ºC

Density:0.906 g/mL at 25ºC

Index of Refraction:n20/D 1.5160

PSA:36.92000

Exact Mass:558.40500

LogP:7.43030

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 1294 3/PG 2

Packing Group:

Contact us for information like MFCD03701633 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,9,9-Di(2-ethylhexyl)fluorene-2,7-diboronic acid bis(1,3-propanediol) ester solution physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,2′-((9,9-Bis(2-ethylhexyl)-9H-fluorene-2,7-diyl)bis(oxy))bis(1,3,2-dioxaborinane) Use and application,9,9-Di(2-ethylhexyl)fluorene-2,7-bis(trimethylene borate) solution technical grade,usp/ep/jp grade.

Related News: he agency said the drugmaker and Emergent must agree that the FDA can share relevant information about the manufacturing of the doses with regulators where the vaccine is shipped. 2-[7-(1,3,2-dioxaborinan-2-yl)-9,9-bis(2-ethylhexyl)fluoren-2-yl]-1,3,2-dioxaborinane manufacturer Once they have decided how to make the compound, our staff in the production department manufacture a high quantity of APIs using the large reactors in our plant. 2-[7-(1,3,2-dioxaborinan-2-yl)-9,9-bis(2-ethylhexyl)fluoren-2-yl]-1,3,2-dioxaborinane supplier Also, states with higher obesity rates also tend to have higher rates of food insecurity, which means lower incomes in general,” she noted. “Bariatric surgery is an expensive proposition, especially if one does not have good insurance coverage for it. 2-[7-(1,3,2-dioxaborinan-2-yl)-9,9-bis(2-ethylhexyl)fluoren-2-yl]-1,3,2-dioxaborinane vendor he agency said the drugmaker and Emergent must agree that the FDA can share relevant information about the manufacturing of the doses with regulators where the vaccine is shipped. 2-[7-(1,3,2-dioxaborinan-2-yl)-9,9-bis(2-ethylhexyl)fluoren-2-yl]-1,3,2-dioxaborinane factory ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.